MS News Note: Facial Surgery, UK MS Rates, Omega 3s, Remyelination

Welcome to “MS News Notes”. In Monday morning’s column, I comment on the multiple sclerosis (MS) news story that caught my eye last week. Let’s see what’s going on:

Surgical treatment of facial pain

I have never heard of surgery being used as a cure for multiple sclerosis. Today’s MS News Story “Surgery was successful for some patients with multiple sclerosis who suffer from facial pain.” Surgery was effective for some people with trigeminal neuralgia, a type of nerve damage that causes facial pain. These were patients who either did not tolerate the drug or responded poorly to it.

In this study of 18 MS patients who underwent a procedure called microvascular decompression (MVD), 71% had good or excellent results compared with 64% who received less invasive treatments. achieved outcomes. However, other patients treated with MVD also had serious complications, including one death.

It seems to me that a very serious discussion of the risks and benefits with a neurologist is necessary before MS patients consider this procedure.

Recommended books

Cerebrovascular | Photo Today's Multiple Sclerosis News | Human Brain Illustration

MS incidence in the UK remains stable

The news article “MS diagnostic rates remain constant for 20 years, large UK study shows” reports that MS incidence rates in the UK have stabilized.

The incidence of MS seen in the country between 2000 and 2002 was 10.4 per 100,000 person-years, compared with 10.6 per 100,000 person-years between 2017 and 2019. You would think that would be good news. But Professor Gavin Giovanoni, a London neurologist and author of the MS-Selfie blog, said the data could be used by the National Health Service to urge more investment in MS services and staffing of hospitals across the country. I am concerned that it will hold back the

On the other hand, according to the Atlas of MS, which tracks MS around the world, “The number of MS patients worldwide will increase from 2.3 million in 2013 to 2.8 million in 2020 and 2.9 in 2023. increased to While I commend the UK’s recent figures, I hope that UK health authorities will take into account the significant increase reported by the MS Atlas when discussing annual budgets for MS treatment and care.

Is there a connection between omega-3s and myelin?

Omega-3 fatty acids are found in fish and some vegetables such as spinach and broccoli. Some people with MS take omega-3 supplements because they believe it makes them feel better. According to one recent study, they may be doing something right.

The new study, reported in “Omega-3 Fatty Acid Transporters Essential for Myelin Sheath Generation: A Study,” suggests that having adequate omega-3 levels is key to maintaining a healthy myelin coating in some nerves. indicates that there is a possibility that Researchers report that certain levels of omega-3 molecules are required to help develop the cells that make myelin in the brain.

This study is based on mouse studies, but I don’t usually comment on that. What happens to rats doesn’t necessarily correlate with what happens to humans. However, her ability to generate myelin is of great interest to her MS patients, so an exception is made here.

Early research brings further promise for remyelination

For me, reducing inflammation and repairing damaged nerve coatings in MS patients is the holy grail of MS treatment. I don’t think it will happen in my lifetime, but the story “Nanocapsules containing retinoic acid may treat inflammation in MS: A study” suggests that these things will eventually lead to MS. It gives me hope that it will happen to others with whom I live.

These researchers believe that retinoic acid, which aids cell growth and development, may reduce inflammation in MS patients and stimulate the growth of myelinating cells in the central nervous system. I hope they are correct and this will lead to further research in this area.

Note: Multiple Sclerosis News Today is a news and information website strictly about this disease. It does not provide medical advice, diagnosis or treatment. This content is not a substitute for professional medical advice, diagnosis or treatment. If you have any questions regarding your medical condition, always seek the advice of your doctor or other qualified healthcare provider. Never disregard or delay seeking professional medical advice because of what you read on this website. The opinions expressed in this column are not those of Multiple Sclerosis News Today or its parent company, Bionews, and are intended to provoke discussion on issues related to multiple sclerosis.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *